Trial Profile
A retrospective study to evaluate the efficacy and safety profile of rivaroxaban following hip and knee arthroplasty.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 14 Jun 2015 Interim Results (n=99) presented at the 20th Congress of the European Haematology Association.